Conley Chee, President & CEO at Syros Pharmaceuticals, Inc. (SYRS), bought 100,000 shares at $1.51 ($161K) on 2024-09-10, disclosed to the SEC on 2024-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.51 | 50,000 | $76K | 46.9% |
| 2 | $1.71 | 50,000 | $86K | 53.1% |
| Total | $1.61 avg | 100,000 | $161K | 100% |